益盛药业(002566) - 2017 Q3 - 季度财报

Financial Performance - Net profit attributable to shareholders increased by 137.68% year-on-year, amounting to CNY 14,662,647.70 for the current period[8]. - Operating revenue for the current period was CNY 255,858,096.99, reflecting a growth of 9.75% compared to the same period last year[8]. - Basic earnings per share rose by 138.17% to CNY 0.0443[8]. - Operating profit increased by 230.61% year-on-year, mainly due to increased operating profit from the subsidiary Han Shen Cosmetics[18]. - Sales revenue from the cosmetic business reached 21,918.23 million yuan, a year-on-year increase of 32.57%[20]. - The company expects net profit attributable to shareholders for 2017 to increase by 350.00% to 400.00%, estimated between 5,937.48 and 6,597.2 million yuan[23]. Assets and Liabilities - Total assets at the end of the reporting period reached CNY 2,691,558,940.85, an increase of 0.78% compared to the end of the previous year[8]. - The total number of shareholders at the end of the reporting period was 22,706[11]. - Accounts payable increased by 60.28% compared to the beginning of the period, mainly due to increased payments owed to suppliers[18]. - Prepayments increased by 92.11% compared to the beginning of the period, mainly due to increased payments for cosmetic raw materials and packaging[18]. - Other current assets decreased by 31.36% compared to the beginning of the period, primarily due to a reduction in deductible input tax from Han Shen Technology[18]. - Construction in progress increased by 197.41% compared to the beginning of the period, due to the purchase of production equipment for oral liquids, ointments, and granules that have not yet been installed[18]. Shareholder Information - The largest shareholder, Zhang Yisheng, holds 39.08% of the shares, totaling 129,348,530 shares[11]. - The company plans to reduce the shareholding of certain shareholders to restore the true shareholding situation[15]. Government Support and Non-Recurring Items - The company received government subsidies amounting to CNY 4,930,829.20 during the reporting period[9]. - Non-recurring gains and losses totaled CNY 3,832,227.78 after tax adjustments[9]. Compliance and Governance - The company has not experienced any non-compliance issues regarding external guarantees during the reporting period[24].